2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as, broad-spectrum inhibitors of human herpesvirus polymerases

被引:41
作者
Schnute, Mark E.
Anderson, David J.
Brideau, Roger J.
Ciske, Fred L.
Collier, Sarah A.
Cudahy, Michele M.
Eggen, MariJean
Genin, Michael J.
Hopkins, Todd A.
Judge, Thomas M.
Kim, Euibong J.
Knechtel, Mary L.
Nair, Sajiv K.
Nieman, James A.
Oien, Nancee L.
Scott, Allen
Tanis, Steven P.
Valliancourt, Valerie A.
Wathen, Michael W.
Wleber, Janet L.
机构
[1] Pfizer Inc, Global Res & Dev, St Louis, MO 63017 USA
[2] Pfizer Inc, Global Res & Dev, Kalamazoo, MI 49007 USA
[3] Pfizer Inc, Global Res & Dev, Ann Arbor, MI 48105 USA
[4] Pfizer Inc, Global Res & Dev, San Diego, CA 92121 USA
[5] Pfizer Inc, Res API, Kalamazoo, MI 49007 USA
关键词
cytomegalovirus; HCMV; varicella-zoster; VZV; HSV;
D O I
10.1016/j.bmcl.2007.03.102
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 2-aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamides have been identified as potent antivirals against human herpesviruses. These compounds demonstrate broad-spectrum inhibition of the herpesvirus polymerases HCMV, HSV-1, EBV, and VZV with high specificity compared to human DNA polymerases. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3349 / 3353
页数:5
相关论文
共 18 条
[1]   SYNTHESIS OF NEW V-TRIAZOLOPYRIMIDINIUM SALTS [J].
BATORI, S ;
MESSMER, A .
JOURNAL OF HETEROCYCLIC CHEMISTRY, 1994, 31 (04) :1041-1046
[2]   Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses [J].
Brideau, RJ ;
Knechtel, ML ;
Huang, A ;
Vaillancourt, VA ;
Vera, EE ;
Oien, NL ;
Hopkins, TA ;
Wieber, JL ;
Wilkinson, KF ;
Rush, BD ;
Schwende, FJ ;
Wathen, MW .
ANTIVIRAL RESEARCH, 2002, 54 (01) :19-28
[3]   ENANTIOSPECIFIC SYNTHESIS OF (+)-(R)-6,7-DIMETHOXY-2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE FROM (+)-(S)-2-METHYLAMINO-1-PHENYLETHANOL (HALOSTACHINE) [J].
COOTE, SJ ;
DAVIES, SG ;
MIDDLEMISS, D ;
NAYLOR, A .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1989, (12) :2223-2228
[4]   Congenital cytomegalovirus infection: Review of the epidemiology and outcome [J].
Gaytant, MA ;
Steegers, EAP ;
Semmekrot, BA ;
Merkus, HMMW ;
Galama, JMD .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2002, 57 (04) :245-256
[5]   Herpes Zoster [J].
Cohen, Jeffrey I. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (03) :255-263
[6]   Varicella [J].
Heininger, Ulrich ;
Seward, Jane F. .
LANCET, 2006, 368 (9544) :1365-1376
[7]   Cytomegalovirus disease in AIDS [J].
Ives, DV .
AIDS, 1997, 11 (15) :1791-1797
[8]   Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline [J].
Knechtel, ML ;
Huang, A ;
Vaillancourt, VA ;
Brideau, RJ .
JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (02) :234-236
[9]   Definitions of cytomegalovirus infection and disease in transplant recipients [J].
Ljungman, P ;
Griffiths, P ;
Paya, C .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (08) :1094-1097
[10]   QUANTIFICATION OF ADHERENT AND NONADHERENT CELLS CULTURED IN 96-WELL PLATES USING THE SUPRAVITAL STAIN NEUTRAL RED [J].
LOWIK, CWGM ;
ALBLAS, MJ ;
VANDERUIT, M ;
PAPAPOULOS, SE ;
VANDERPLUIJM, G .
ANALYTICAL BIOCHEMISTRY, 1993, 213 (02) :426-433